MetLife, Inc. stock is up 6.41% since 30 days ago. The next earnings date is Jan 31, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 23 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 3 PUTs, 7 CALLs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
17 Nov 19:15 | 21 Jun, 2024 | 55.00 | 1008 | ||
17 Nov 20:28 | 19 Jan, 2024 | 70.00 | 9086 | ||
20 Nov 15:34 | 15 Mar, 2024 | 62.50 | 454 | ||
21 Nov 19:13 | 19 Jan, 2024 | 60.00 | 16203 | ||
22 Nov 16:26 | 17 Jan, 2025 | 65.00 | 369 | ||
22 Nov 16:34 | 17 Jan, 2025 | 65.00 | 369 | ||
22 Nov 17:34 | 17 Jan, 2025 | 72.50 | 880 | ||
24 Nov 15:40 | 19 Dec, 2025 | 62.50 | 380 | ||
24 Nov 16:12 | 17 Jan, 2025 | 55.00 | 1490 | ||
28 Nov 17:32 | 15 Mar, 2024 | 55.00 | 534 |
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services. It operates through five segments: U.S., Asia, Latin America, Europe, Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages.